The CARMA Technique Study
The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a "Novel" Approach to Reduce Polyp Recurrence
Princess Alexandra Hospital, Brisbane, Australia
60 participants
Nov 1, 2021
INTERVENTIONAL
Conditions
Summary
Colonoscopic removal of polyps is an important and well-established tool in the prevention of colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with resultant development of interval cancers, remains a problem; this most commonly stems from unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed that will allow endoscopists to consistently achieve a clear margin of resection. The investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will address this problem. This novel technique focuses on a standardised assessment of the resection margin after endoscopic polypectomy utilising available standard high-definition video endoscopes with imaging features including narrow band imaging (NBI) and magnification endoscopy.
Eligibility
Inclusion Criteria2
- Patients with colonic polyps will be considered following below criteria
- \- any polypectomy (though only a maximum of two polyps from one individual participant)
Exclusion Criteria6
- polyps less than 10mm which were resected under endoscopic view with a definite > 1mm clear margin
- scar site recurrence polyps
- polyps with endoscopic evidence of invasion
- pedunculated polyps
- pseudopolyps
- participants who will not be available for follow up endoscopy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Once standard polyp resection and assessment of the polypectomy site without magnification is completed, the CARMA technique will be applied. This will involve an assessment of the entire polypectomy margin using cap assisted magnification endoscopy with the ability to also use NBI (at the endoscopist's discretion) and documentation of any residual polyp noted.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05099432